Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Change in Acquisitions & Divestments: 2023-2025

Historic Change in Acquisitions & Divestments for Centessa Pharmaceuticals (CNTA) over the last 2 years, with Sep 2025 value amounting to $107.7 million.

  • Centessa Pharmaceuticals' Change in Acquisitions & Divestments rose 139.32% to $107.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $251.0 million, marking a year-over-year increase of 26.35%. This contributed to the annual value of $171.8 million for FY2024, which is 24.45% up from last year.
  • Centessa Pharmaceuticals' Change in Acquisitions & Divestments amounted to $107.7 million in Q3 2025, which was up 149.09% from $43.2 million recorded in Q2 2025.
  • Centessa Pharmaceuticals' 5-year Change in Acquisitions & Divestments high stood at $107.7 million for Q3 2025, and its period low was $25.0 million during Q4 2024.
  • In the last 3 years, Centessa Pharmaceuticals' Change in Acquisitions & Divestments had a median value of $51.8 million in 2023 and averaged $59.5 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first slumped by 51.76% in 2024, then soared by 139.32% in 2025.
  • Centessa Pharmaceuticals' Change in Acquisitions & Divestments (Quarterly) stood at $51.8 million in 2023, then crashed by 51.76% to $25.0 million in 2024, then skyrocketed by 139.32% to $107.7 million in 2025.
  • Its Change in Acquisitions & Divestments was $107.7 million in Q3 2025, compared to $43.2 million in Q2 2025 and $75.1 million in Q1 2025.